Fig. 2From: PRX1 knockdown potentiates vitamin K3 toxicity in cancer cells: a potential new therapeutic perspective for an old drugCell viability of Prx1+ and Prx1– cells in response to different anti-cancer drugs. Both Prx1+ and Prx1– cells were treated with different doses of indicated drugs for defined times. Cell viabilities were monitored by MTT cell viability assay. Data are mean ± SD of at least 2 independent experimentsBack to article page